Urology Surgical Instruments Market

The Urology Surgical Instruments Market is valued at USD 13.9 Bn in 2026 and is projected to reach USD 22.8 Bn,  growing at a CAGR of 6% by 2033.

Market Analysis in Brief

The notable rise in healthcare spending over the recent past, and expenditure on the development of surgical and healthcare infrastructure are primarily driving the expansion of the urology surgical instruments market. Growing worldwide preference for minimally invasive surgical techniques also contributes largely toward the progression of the market. It is anticipated that the favorable government initiatives, reimbursement policies in developed economies, and the increased demand for minimally invasive surgeries will further accelerate market expansion. However, the market still stares at the prevalent concerns around potential infections via various urology surgical instruments. Increasing prevalence of urological illnesses like urinary tract infections (UTI), prostate cancer, chronic kidney disease (CKD), and benign prostatic hyperplasia (BPH) will keep the market buoyant.

Key Report Findings

• In 2021, the urology surgical instruments market attained a valuation beyond US$9.8 Bn
• Some of the widely prevalent conditions such as UTIs, CKD, BHP, prostate cancer, and urologic cancers provide a heavy impetus to demand for urological surgical instruments
• Sales of consumables and accessories dominant
• North America leads the pack as suggested by the primary regional analysis

Growth Drivers

Growing Cases of Kidney Diseases

The different kidney disorders include, among others, hemolytic-uremic syndrome, renal cyst, cystic kidney diseases, chronic kidney disease, and lupus nephritis. Most kidney illnesses result in renal failure, necessitating an early diagnosis and immediate medical intervention. End-stage renal disease (ESRD) affects more than 500,000 Americans each year, according to a September 2021 paper by Onecia Benjamin and Sarah L. Lappin that was published in the National Institutes of Health.

Age affects the prevalence of CKD, with people over 60 seeing the greatest rate of progression. Between the ages of 18, 44, and 65 years and older, the prevalence is 6.0% and 38.1%, respectively. According to the National Institute on Diabetes and Digestive and Kidney Diseases (NIDDK), end-stage renal disease (ESRD), also known as ESKD, affected over 786,000 people in the United States in 2020, with 71% of them needing dialysis and 29% needing a kidney transplant.

However, most people do not receive an early diagnosis, which ultimately results in mortality for everyone. As a result, the government's assistance through reimbursement and product innovation to create a low-cost and effective treatment are some factors anticipated to boost the urology surgical instruments market throughout the projection period.

Increasing Number of Hospitals Investing in Endoscopy and Laparoscopy Facilities

Hospitals that offer urology procedures like endoscopy and laparoscopy are becoming more common as patients express a growing preference for minimally invasive techniques. Existing endoscopic units in hospitals are being expanded and new technology is being purchased. A similar scenario exists across multiple regions around the world. New Greater Manchester Endoscopy Modular Unit in Bury was launched in January 2021 by Fairfield General Hospital.

Greater Manchester Health and Social Care Partnership has given the unit a special order to help with the endoscopic service delivery disrupted by the pandemic. Growing preference for urology surgical instruments like endoscopes, and endovision systems for efficient treatment and management of urological conditions, is anticipated to grow as hospitals choose to acquire cutting-edge-enabled instruments and expanding units, and the establishment of new centres.

Growth Challenges

Premium Pricing

One of the main factors hindering urology surgical instruments market growth is the high cost of urology endoscopes, and endovision systems, especially in price-sensitive markets like Asia Pacific. Healthcare providers generally lack the financial capacity to invest in such expensive, complex equipment, particularly in developing nations like Brazil, and Mexico.

Furthermore, staff members need to receive training in the proper use and upkeep of urology surgical instruments. Because incorrectly reprocessed endoscopes can cause cross-contamination and expose patients to infections, maintaining urological equipment such as endoscopic equipment, is crucial. The already high costs may rise as a result. This is one of the main causes for why doctors, and consumers opt for less expensive alternative treatments.

The absence of supportive FDA revisions for medical devices could also pose a measurable threat to the urology surgical instruments market expansion, shows research.

Overview of Key Segments

Consumables and Accessories Dominant Category

In the global urology surgical instruments market, the consumables and accessories segment outperformed the other segments in terms of revenue share. Frequent use, and disposable nature are the main factors propelling this segment of the urology surgical instruments market. The demand for these goods is also anticipated to increase in the upcoming years as urological operations increase globally.

Additional categories of consumables and accessories include stone baskets/retrieval devices and extractors, fluid flushing tools, stents, needle forceps, and needle holders, connecting tubes, distal attachments, overtures, drainage bags, clamps, biopsy tools, catheters, dilator sets, and ureteral access sheaths, guidewires, surgical dissectors, and others.

Besides, endoscopes represent the second largest product category in the urology surgical instruments market. One of the main factors propelling this segment is the rising need for less invasive approaches in diagnostic and therapeutic procedures. Additionally, factors that are anticipated to enhance demand for endoscopes over the forecast period include rise in private player investments, increase in public sector grants or funds, and growth in the number of hospitals, and clinics.

CKD Remains a Prominent Category

In the forecast period, the CKD segment held the largest urology surgical instruments market share, and it is anticipated that it will continue to surge ahead as the key application category during the forecast period. This can be ascribed to the increasing prevalence of CKD, the expansion of clinical trials for novel, non-invasive therapies for these conditions, and global government initiatives.

Early identification and therapy aid in managing the disease by preventing further kidney damage. ESRD, a serious ailment that poses a serious risk to one's life, could result from not receiving treatment. As a result, the demand for urological interventions to control kidney illnesses is being driven by their rising occurrence as well as the health consequences linked to them, which in turn is boosting the urology surgical instruments market.

Growth Opportunities Across Regions

Primacy of North America Intact with Increasing Cases of Urologic Cancers

Over the forecast period, it is anticipated that the North American urology surgical instruments market will account for the largest revenue share. Growing geriatric populations in the US, and Canada, increasing rates of urologic cancers and disorders, hospitals purchasing more urology equipment, an increase in the number of urologists, favorable reimbursement conditions, and rising healthcare spending on urology disorders are some of the major factors anticipated to boost the regional urology surgical instruments market over the course of the forecast period.

The US is one of the major markets in the area, and its expansion can be attributed to the high prevalence of patients with urological disorders, the rise in urology procedures, the rise in hospital spending on the acquisition of urological surgical instruments, and the ongoing introduction of technologically cutting-edge products. In the upcoming years, it is anticipated that the availability of reimbursement for urology operations would increase the volume of urological procedures performed and, consequently, the need for related instruments.

Market in Asia Pacific Stable

Asia Pacific urology surgical instruments market is anticipated to experience stable revenue growth throughout the forecast period due to an increase in discretionary income. In the upcoming years, it is anticipated that the urology surgical instruments market will gain significantly from the expansion of free trade agreements between Asian and Western nations, rising government spending on urology care, and stricter regulations governing the use of invasive devices. The improved healthcare infrastructure in China, and India, and the rapid expansion of medical tourism will also support market growth.

To keep up with the increased demand for urological procedures, numerous public and private institutions in China, Australia, Modern Zealand, Malaysia, Singapore, Japan, Indonesia, and India are investing in new urology technology.

Key Companies in Global Urology Surgical Instruments Market

Some of the major players in the urology surgical instruments market include 

• Olympus Corporation
• Karl Storz SE & Co. KG
• Boston Scientific Corporation
• Medtronic plc
• Becton, Dickinson and Company (BD)
• Cook Medical
• Teleflex Incorporated
• Stryker Corporation
• Richard Wolf GmbH
• Coloplast A/S
• ConMed Corporation
• Zimmer Biomet
• Smith & Nephew plc
• Dornier MedTech
• Peters Surgical Group

Notable Developments

• In November 2020, the FDA gave Baxter International Inc. (US) permission to use the Sharesource connectivity platform with its Homechoice Claria automated peritoneal dialysis system
• In May 2019, the opening of a new distribution facility in Knoxville, Tennessee, was announced by Fresenius Medical Care AG & Co. KGaA (Germany). This expansion was intended to facilitate the distribution of goods required for in-center hemodialysis therapy

Global Urology Surgical Instruments Market Segmentation is Described Below:

Product

• Endoscopes
• Envision Systems
• Peripheral Systems
• Consumables & Accessories

Application

• Chronic Kidney Diseases (CKD)
• Benign Prostatic Hyperplasia (BPH)
• Urinary Stones
• Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP)
• Oncology
• Other Applications

Region

• North America
• Europe
• Asia Pacific
• Latin America
• MEA